
About company
Excivion was formed in response to the need to develop affordable solutions to the present and looming health crises of a changing world. Excivion's founder and CEO, Peter Laing PhD, is an experienced executive and non-executive director of biotechnology companies having worked as R&D Director and Chief Operating Officer of plc companies, and having provided advice to venture capital and institutioal investors, plcs and NGOs in the field of biotechnology. He has developed collaborations with several of the world's top pharma and biotech companies that have resulted in products of global significance. He is a winner of the UKTI (Innovate UK) Biotech Entrepreneur of the Year award. The name 'Excivion" was coined to connote the need to take an objective and strategic view of these problems - requiring 'experience', 'incisiveness' and 'vision': the art of 'seeing the wood for the trees'.